Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Press

Showing results (231-240 of 273) with videos related to

Pageof 28
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancerEdward B Garon, Jill M Siegfried, Laura P Stabile, et al.
Archives of Pathology & Laboratory Medicine|June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Human Molecular Genetics|August 20, 2011
Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African AmericansFang Chen, Gary K Chen, Robert C Millikan, et al.
Plos One|March 8, 2013
A genome-wide scan for breast cancer risk haplotypes among African American womenChi Song, Gary K Chen, Robert C Millikan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP Tarantino, G Viale, M F Press, et al.
Cancer Research Communications|September 22, 2025
Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor TypesDorothy Hallberg, Alice C Eastman, Shashikant Koul, et al.
Human Molecular Genetics|May 24, 2014
A comprehensive examination of breast cancer risk loci in African American womenYe Feng, Daniel O Stram, Suhn Kyong Rhie, et al.
Cancer Discovery|September 30, 2024
Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein BiomarkersJamie E Medina, Akshaya V Annapragada, Pien Lof, et al.
NPJ Breast Cancer|June 27, 2017
A functionally significant SNP in TP53 and breast cancer risk in African-American womenMaureen E Murphy, Song Liu, Song Yao, et al.
Pageof 28

Showing results (231-240 of 273) with videos related to

Sort By:
Pageof 28
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancerEdward B Garon, Jill M Siegfried, Laura P Stabile, et al.
Archives of Pathology & Laboratory Medicine|June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Human Molecular Genetics|August 20, 2011
Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African AmericansFang Chen, Gary K Chen, Robert C Millikan, et al.
Plos One|March 8, 2013
A genome-wide scan for breast cancer risk haplotypes among African American womenChi Song, Gary K Chen, Robert C Millikan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP Tarantino, G Viale, M F Press, et al.
Cancer Research Communications|September 22, 2025
Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor TypesDorothy Hallberg, Alice C Eastman, Shashikant Koul, et al.
Human Molecular Genetics|May 24, 2014
A comprehensive examination of breast cancer risk loci in African American womenYe Feng, Daniel O Stram, Suhn Kyong Rhie, et al.
Cancer Discovery|September 30, 2024
Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein BiomarkersJamie E Medina, Akshaya V Annapragada, Pien Lof, et al.
NPJ Breast Cancer|June 27, 2017
A functionally significant SNP in TP53 and breast cancer risk in African-American womenMaureen E Murphy, Song Liu, Song Yao, et al.
Pageof 28